Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting

Annals of Medicine

Volumn 40, Issue 6, 2008, Pages 437-443

  Mäkikallio, Timo H ^a   Niemelä, Matti ^b   Kervinen, Kari ^b   Jokinen, Vesa ^b   Laukkanen, Jari ^b   Ylitalo, Kari ^b   Tulppo, Mikko P ^b   Juvonen, Jukka ^b   Huikuri, Heikki V ^b  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Left main coronary artery stenosis; Mortality; Percutaneous coronary intervention

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 50649119871     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890701879790     Document Type: Article

References (30)

1. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 Guidelines update for coronary artery bypass graft surgery. Circulation. 2004;110:1168-76.
2. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804-47.
3. Varnauskas E, for the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery study. N Engl J Med. 1988;319:332-7.
4. Chaitman BR, Fisher LD, Bourassa MG, Davis K, Rogers WJ, Maynard C, et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol. 1981;48:765-77.
5. Taylor HA, Deumite NJ, Chaitman BR, Davis KB, Killip T, Rogers WJ. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. Circulation. 1989;79:1171-9.
6. O'Keefe JH Jr, Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol. 1989;64:144-7.
7. Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for PercutaneousTransluminal Angioplasty). J Am Coll Cardiol. 2001;37:2215-39.
8. Silvestri M, Barragan P, Sainsous J, Sainsous J, Bayet G, Simeoni JB, et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol. 2000;35:1543-50.
9. Lopez JJ, Ho KK, Stoler RC, Caputo RP, Carrozza JP, Kuntz RE, et al. Percutaneous treatment of protected and unprotected left main coronary artery stenoses with new devices: immediate angiographic results and intermediate-term follow-up. J Am Coll Cardiol. 1997;29:345-52.
10. Tan WA, Tamai H, Park SJ, Plokker HW, Nobuyoshi M, Suzuki T, et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation. 2001;104:1609-14.
11. Chieffo A, Stankovic G, Bonizzoni E, Bonizzoni E, Tsagalou E, Iakovou I, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation. 2005;111:791-5.
12. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol. 2005;45:351-6.
13. Tanigawa J, Sutaria N, Goktekin O, Di Mario C. Treatment on unprotected left main coronary artery stenosis in the drug-eluting stent era. J Interv Cardiol. 2005;18:455-65.
14. Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for percutaneous treatment of left main coronary artery disease: insights from the Rapamysin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005;111:1383-9.
15. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis; a single-center experience. Circulation. 2006;113:2542-7.
16. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2006;47:864-70.
17. Palmerini T, Marzocchi A, Marrozzini, Reggiani LB, Savini C, Marinelli G, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol. 2006;98:54-9.
18. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, et al. Serial angiographic follow-up of sirolimus-eluting stent implantation for unprotected left main coronary artery revascularization. J Am Coll Cardiol. 2006;47:871-7.
19. d'Allonnes FR, Corbineau H, Le Breton H, Leclercq C, Leguerrier A, Daubert C. Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery. Heart. 2002;87:544-8.
20. Ellis SG, Hill CM, Lytle BW. Spectrum of surgical risk for left main coronary stenoses: benchmark for potentially competing percutaneous therapies. Am Heart J. 1998;135:335-8.
21. Buszman P, Peszek-Przybyla E, Milewski K, Zurakowski A, Debinski M, Kiesz S, et al. Unprotected left main stenting: early and late results: LE MANS Registry. Am J Cardiol. 2005;96:205H.
22. Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol. 2001;37:832-8.
23. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol. 2002;40:1961-7.
24. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR, Spanos V, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244-9.
25. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, et al. PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446-54.
26. Stroupe KT, Morrison DA, Hlatky MA, Barnett PG, Cao L, Lyttle C, et al. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients. Circulation. 2006;114:1251-7.
27. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J. 2006;151:1194-204.
28. Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era - a report from the American College of Cardiology-National Cardiovascular data registry (ACC-NCDR). Catheter Cardiovasc Interv. 2006;68:867-72.
29. Powell BD, Rihal CS, Bell MR, Zehr KJ, Holmes DR. Anticipated impact of drug-eluting stents on referral patterns for coronary artery bypass graft surgery: a population-based angiographic analysis. Mayo Clin Proc. 2004;79:769-72.
30. Kereiakes DJ, Faxon DP. Left main coronary revascularization at the crossroads. Circulation. 2006;113:2480-4.